Doxefazepam

NERVOUS SYSTEM

Key facts

Doxefazepam is a drug catalogued in DrugCentral. Recorded indications include Insomnia.

• Indications: Insomnia.
• ATC code: N05CD12 (Benzodiazepine derivatives).
• Molecular formula: C17H14ClFN2O3; molecular weight 348.76 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Insomnia

ATC classification

ATC code	Therapeutic hierarchy
N05CD12	NERVOUS SYSTEM › PSYCHOLEPTICS › HYPNOTICS AND SEDATIVES › Benzodiazepine derivatives

Chemical structure

• Molecular formula: C₁₇H₁₄ClFN₂O₃
• Molecular weight: 348.76 g/mol
• CAS number: 40762-15-0
• InChIKey: VOJLELRQLPENHL-UHFFFAOYSA-N
• PubChem CID: 38668

OCCN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C1=C(F)C=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Doxefazepam used for?

DrugCentral lists the following indications for Doxefazepam: Insomnia.

What is the chemical formula of Doxefazepam?

Doxefazepam has the molecular formula C17H14ClFN2O3 and a molecular weight of 348.76 g/mol.

Sources

• DrugCentral drug card 955 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL64677 — compound record and bioactivity
• PubChem CID 38668 — chemical identifiers
• DrugBank DB13837 — drug record
• FDA UNII 231RV72C8L — substance identity

How this page is built: methodology · editorial policy & corrections.